Tyce Gm

L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects.

Muenter, Tyce Gm · PubMed · 1971 · 242 citations

Plasma L-dopa Concentration, Medicine, Parkinson Disease +7

Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease.

Muenter, Sharpless Ns, Tyce Gm et al. · PubMed · 1977 · 151 citations

Functional aspects of bulbospinal monoaminergic projections in modulating processing of somatosensory information.

Yaksh Tl, Donna L. Hammond, Tyce Gm · PubMed · 1981 · 84 citations

Neuropathic Pain, Molecular Pain, Neurotransmission +21

3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.

Muenter, Dinapoli Rp, Sharpless Ns et al. · PubMed · 1973 · 30 citations

Neurodegenerative Diseases, Medicine, Parkinson Disease +6

Acetylcholine--inhibition of transmitter release from adrenergic nerve terminals mediated by muscarinic receptors.

Shepherd Jt, RR Lorenz, Tyce Gm et al. · Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) · 1978 · 22 citations

Synaptic Transmission, Adrenergic Nerve Terminals, Neurotransmitter +20